Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$167K Buy
442
+37
+9% +$19K ﹤0.01% 1515
2026
Q2
$323K Buy
405
+60
+17% +$39.9K ﹤0.01% 1319
2026
Q1
$188K Buy
+345
New +$141K ﹤0.01% 1367
2024
Q1
– Sell
-50
Closed -$2.34K – 1932
2023
Q4
$2.34K Buy
+50
New +$2.28K ﹤0.01% 1523
2017
Q4
– Sell
-869
Closed -$58K – 1852
2017
Q3
$58K Sell
869
-46
-5% -$2.89K ﹤0.01% 667
2017
Q2
$55K Buy
915
+862
+1,626% +$55.7K ﹤0.01% 659
2017
Q1
$4K Buy
+53
New +$3.71K ﹤0.01% 1042

Other funds holding AGX

AssetMark's AGX Position: Q3 2026 in Review

AssetMark increased its Argan (AGX) stake by 9.1% in Q3 2026, buying an estimated $19K and bringing the position to 442 shares worth $167K. The position accounts for ﹤0.01% of the portfolio, ranked #1515.

AssetMark first reported a position in AGX in Q1 2017 and has held it in 7 quarters since. The position peaked at $323K in Q2 2026. 403 funds tracked by Wall St. Rank hold AGX as of Q3 2026.

  • AssetMark held 442 shares of Argan worth $167K as of Q3 2026.
  • AssetMark bought 37 Argan shares in Q3 2026, an estimated $19K.
  • Argan made up ﹤0.01% of AssetMark's portfolio in Q3 2026, its #1515 holding.
  • AssetMark first reported a position in Argan in Q1 2017 and has held it in 7 quarters since.
  • AssetMark's Argan position peaked at $323K in Q2 2026.
  • 403 funds tracked by Wall St. Rank held Argan as of Q3 2026.

Based on AssetMark's 13F filing for Q3 2026, filed 21 Oct 2026.